Orthopedic Surgery Doctors in Brigham City, UT Accepting Medicare

6 Orthopedic Surgery doctors found. Showing 1 - 6

Daniel J Johnson, DO Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 970 Medical Dr Ste 309, Brigham City, UT 84302 Phone: 385-238-3375    Fax: 385-238-3376

Dr. Matthew F Bitner, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 990 Medical Dr, Suite G5, Brigham City, UT 84302 Phone: 435-734-2151    Fax: 435-734-2192

Dr. Michael H Sumko, DO Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 990 Medical Dr, Suite G5, Brigham City, UT 84302 Phone: 435-734-2151    Fax: 435-734-2192

Dr. Michael Voss Hoffman, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1030 S Medical Dr Ste A, Brigham City, UT 84302 Phone: 435-723-9700    Fax: 435-723-9710

Dr. Daniel Foulger Tensmeyer, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1030 Medical Dr, Suite A, Brigham City, UT 84302 Phone: 435-723-9700

Dr. Dewey C Mackay Iii, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 950 So Medical Dr, Suite 106, Brigham City, UT 84302 Phone: 435-723-1747    Fax: 435-723-6851

News Archive

Bioethics leader proposes bold and controversial approach to fight obesity epidemic

Arguing that obesity "may be the most difficult and elusive public health problem the United States has ever encountered" and that anti-obesity efforts having made little discernible difference, Daniel Callahan, co-founder and President Emeritus of The Hastings Center, proposes a bold and controversial approach to fighting the epidemic.

New DVS radiation measurement device for prostate cancer treatment

John Theurer Cancer Center at Hackensack University Medical Center announced today that it is one of two cancer centers in the tri-state area currently implanting a wireless radiation sensor, known as DVS. John Theurer Cancer Center radiation oncologists can now receive data immediately post- treatment on the precise amount of radiation being delivered to tumors and surrounding tissue for prostate cancer treatments.

Amorfix Life Sciences signs licensing agreement with PREVENT

Amorfix Life Sciences Ltd. and Pan-Provincial Vaccine Enterprise Inc. of Saskatoon, Saskatchewan, today announced that the two groups have entered into a licensing agreement granting PREVENT exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis vaccines.

New PTLD Guideline highlighted at NCCN Annual Conference

A new Guideline detailing diagnosis, workup, and treatment options for Post-Transplant Lymphoproliferative Disorder, as well as stronger recommendations for therapies in follicular lymphoma, topped the list of highlights in a presentation of the updated NCCN Guidelines for Non-Hodgkin's Lymphomas.

Research roundup: Putting good science into practice; shifting hospital costs; finding savings in Mass.

In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.

Read more Medical News

› Verified 9 days ago